Silvia ruiz velasco

Dr. Silvia ruiz velasco

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2006 in Environmental Health Perspectives
Verified
Journal Article
Open access
LSLourdes Schnaas
Lourdes Schnaas
SRStephen Rothenberg
Stephen Rothenberg
MFMaria-Fernanda Flores
Maria-Fernanda Flores
SMSandra Martinez
Sandra Martinez
CHCarmen Hernandez
Carmen Hernandez
EPEstela Perroni
Estela Perroni
Low-level postnatal lead exposure is associated with poor intellectual development in children, although effects of prenatal exposure are less well studied. We hypothesized that prenatal lead exposure would have a more powerful and lasting impact on child ...

1 July 1998 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
IRIsabelle Romieu
Isabelle Romieu
FMFernando Meneses
Fernando Meneses
MRMatiana Ramirez
Matiana Ramirez
SVSilvia ruiz velasco
Silvia ruiz velasco
RPRogelio Perez Padilla
Rogelio Perez Padilla
BBBert Brunekreef
Bert Brunekreef
Ozone exposure has been related to adverse respiratory effects, in particular to lung function decrements. Antioxidant vitamins are free-radical scavengers and could have a protective effect against photo-oxidant exposure. To evaluate whether acute effects of ozone on lung functions could be attenuated by antioxidant vitamin supplementation, we conducted a randomized trial using a double-blind crossover design. Street workers (n = 47) of Mexico City were randomly assigned to take daily a supplement (75 mg vitamin E, 650 mg vitamin C, 15 mg beta carotene) or a placebo and were followed from March to August 1996. Pulmonary function tests were done twice a week at the end of the workday. During the follow-up, the mean 1-h maximum ozone level was 123 ppb (SD = 40). During the first phase, ozone levels were inversely associated with FVC (beta = − 1.60 ml/ppb), FEV1 (beta = − 2.11 ml/ppb), and FEF25–75 (beta = − 4.92 ml/ppb) (p < 0.05) in the placebo group but not in the supplement group. The difference between the two groups was significant for FVC, FEV1, and FEF25–75 (p < 0.01). During the second phase, similar results were observed, but the lung function decrements in the placebo group were smaller, suggesting that the supplementation may have had a residual protective effect on the lung. These results need to be confirmed in larger supplementation studies.

29 April 1998 in Allergy
Verified
Journal Article
Closed access
PDF file
IRI. Rosas
I. Rosas
HMH. A. McCartney
H. A. McCartney
RPR. W. Payne
R. W. Payne
CCC. Calderón
C. Calderón
JLJ. Lacey
J. Lacey
SVSilvia ruiz velasco
Silvia ruiz velasco

1 September 2008 in Environmental Health Perspectives
Verified
Journal Article
Open access
IRIsabelle Romieu
Isabelle Romieu
RGRaquel Garcia-Esteban
Raquel Garcia-Esteban
JSJordi Sunyer
Jordi Sunyer
CRCamilo Rios
Camilo Rios
MAMireya Alcaraz-Zubeldia
Mireya Alcaraz-Zubeldia
FHFernando Holguin
Fernando Holguin
Background: The mechanisms of particulate matter (PM)-induced health effects are believed to involve inflammation and oxidative stress. Increased intake of omega-3 polyunsaturated fatty acids (n-3 PUFA) appears to have anti-inflammatory effects. Objective: As part of a trial to evaluate whether n-3 PUFA supplementation could protect against the cardiac alterations linked to PM exposure, we measured biomarkers of response to oxidative stimuli [copper/zinc (Cu/Zn) superoxide dismutase (SOD) activity, lipoperoxidation (LPO) products, and reduced glutathione (GSH)] and evaluated the impact of supplementation on plasma levels. Methods: We recruited residents from a nursing home in Mexico City chronically exposed to PM ≤2.5 μm in aerodynamic diameter (PM2.5) and followed them from 26 September 2001 to 10 April 2002. We randomly assigned subjects in a double-blind fashion to receive either fish oil (n-3 PUFA) or soy oil. We measured PM2.5 levels indoors at the nursing home, and measured Cu/Zn SOD activity, LPO products, and GSH at different times during presupplementation and supplementation phases. Results: Supplementation with either fish or soy oil was related to an increase of Cu/Zn SOD activity and an increase in GSH plasma levels, whereas exposure to indoor PM2.5 levels was related to a decrease in Cu/Zn SOD activity and GSH plasma levels. Conclusion: Supplementation with n-3 PUFA appeared to modulate the adverse effects of PM2.5 on these biomarkers, particularly in the fish oil group. Supplementation with n-3 PUFA could modulate oxidative response to PM2.5 exposure.

1 May 2001 in Pediatrics
Verified
Journal Article
Closed access
PDF file
LSLuz Helena Sanı́n
Luz Helena Sanı́n
TGTeresa González-Cossı́o
Teresa González-Cossı́o
IRIsabelle Romieu
Isabelle Romieu
KPKaren Eileen Peterson
Karen Eileen Peterson
SVSilvia ruiz velasco
Silvia ruiz velasco
HHHoward Hu
Howard Hu
Introduction. Transfer of lead from bone to the bloodstream increases during lactation. However, the effect of maternal lead burden on growth in breastfed newborns is still unknown. This study examined early postnatal growth in a cohort of healthy breastfed newborns in relation to maternal bone lead burden. Methods. Lead levels were measured among 329 mother–infant pairs in umbilical cord blood at birth and in maternal and infant venous blood at 1 month postpartum. Maternal evaluations at 1 month postpartum included lead measures in blood and bone (measured in the tibia and the patella). Blood lead was determined by graphite furnace atomic absorption spectrophotometry. Bone lead was measured by109Cd Kx-radiograph fluorescence instrument. The primary endpoints were attained weight 1 month of age, and weight gain from birth to 1 month of age, which were analyzed in relation to lead biomarkers and relevant covariates by linear regression models. Results. Infants studied had an average weight gain of 33.1 g/day (standard deviation [SD] = 11.6). Mean infant (at 1 month of age) and maternal blood lead levels were 5.6 μg/dL (SD = 3.0) and 9.7 μg/dL (SD = 4.1), respectively. Mean maternal bone lead levels were 10.1 μg of lead/g (SD = 10.3) and 15.29 μg of lead/g (SD = 15.2) of bone mineral for tibia and patella, respectively. Infant blood lead levels were inversely associated with weight gain, with an estimated decline of 15.1 g per μg/dL of blood lead. Children who were exclusively breastfed had significantly higher weight gains; however, this gain decreased significantly with increasing levels of patella lead. The multivariate regression analysis predicted a 3.6-g decrease in weight at 1 month of age per μg of lead per gram bone mineral increase in maternal patella lead levels. Conclusions. Maternal lead burden is negatively associated to infant attained weight at 1 month of age and to postnatal weight gain from birth to 1 month of age. Additional studies are needed to better understand this source of exposure and to develop interventions to minimize its impact.

21 September 2005 in Journal of Exposure Science & Environmental Epidemiology
Verified
Journal Article
Closed access
MVMaite Vallejo
Maite Vallejo
SVSilvia ruiz velasco
Silvia ruiz velasco
JGJesus Antonio Gonzalez- Hermosillo Gonzalez
Jesus Antonio Gonzalez- Hermosillo Gonzalez
VBVíctor H Borja-Aburto
Víctor H Borja-Aburto
MCManuel Cárdenas
Manuel Cárdenas